Daniel Cheung, co-founder of Syncracy Capital, says Hyperliquid’s native token HYPE is beginning to resemble Solana’s setup before its last major run, arguing thatDaniel Cheung, co-founder of Syncracy Capital, says Hyperliquid’s native token HYPE is beginning to resemble Solana’s setup before its last major run, arguing that

Hyperliquid Looks Like Solana At $20 Last Cycle, Daniel Cheung Says

2026/03/12 13:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Daniel Cheung, co-founder of Syncracy Capital, says Hyperliquid’s native token HYPE is beginning to resemble Solana’s setup before its last major run, arguing that the protocol has become the clearest center of real trading activity in crypto. In a series of posts on X over the past month, Cheung laid out an increasingly aggressive thesis: Hyperliquid is not just outperforming within crypto, but could emerge as a broader financial trading platform with appeal beyond the sector.

Cheung’s most direct comparison came this week. “HYPE at $35 feels similar to SOL at $20 before its last cycle rally,” he wrote, framing Hyperliquid as an early-stage winner before a broader market expansion. He tied that view to what he sees as the protocol’s current market position: “Hyperliquid is currently the main chain where trading activity is happening and the only chain bringing new users into crypto right now given its offering around 24/7 markets.”

What Cheung appears to be invoking is Solana’s move from a battered late-2022 asset into one of the cycle’s biggest winners. After trading around $8 at the end of 2022 and still hovering near $23 in September 2023, SOL eventually climbed to a fresh all-time high of $295.83 in mid-January 2025. From a $20 reference point, that would imply a rally of roughly 1,379%.

That argument is notable because it does not rest primarily on meme-driven activity, which has often powered attention cycles elsewhere. Cheung said Hyperliquid is “gaining significantly more media attention and respect” because its use cases are “centered around much more than dogshit memes.” In his telling, that gives the project a stronger foundation if speculative conditions improve again.

Across several posts, Cheung repeatedly described Hyperliquid less as a single-app crypto trade and more as a category-defining trading venue. On Feb. 28, he wrote, “Becoming more clear by the day that Hyperliquid is the financial trading platform of the future and that generational wealth will be made longing this coin. Think this has a chance to flip Robinhood, Interactive Brokers etc… Hyperliquid is out innovating peers.”

That is a large claim, and Cheung presented it as a product and market-structure thesis rather than a short-term price call alone. His view appears to hinge on two linked assumptions: first, that perpetual futures become a much larger category than the market currently prices in, and second, that Hyperliquid captures a disproportionate share of that expansion because it is already where users are trading.

He made that point more explicitly on Feb. 12, when he said investors were missing “two things” in the current market. The first was that “HYPE is the most exciting startup not in AI and will eventually flip COIN and HOOD.” The second was that “the perps category will be bigger than anyone expects,” adding that another asset, LIT, looked deeply undervalued relative to HYPE on a fee basis.

Cheung’s posts also make clear that timing matters. On March 9, he said “HYPE to $120+” would be “pretty easy once the crypto bull market comes back,” before adding: “We are close.” That suggests his target is not based on Hyperliquid operating in isolation, but on the idea that a renewed bull phase would amplify an already strong relative position. Notably, BitMEX founder Arthur Hayes recently argued that HYPE could reach $150 until August this year.

At press time, HYPE traded at $36.16.

Hyperliquid price chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift

Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift

The post Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift appeared on BitcoinEthereumNews.com. RBA Rate Hike: Standard Chartered’s Critical
Share
BitcoinEthereumNews2026/03/12 16:05
X1 EcoChain Partners with Symbiosis to Pioneer Cross-Chain Interoperability Ahead of Mainnet Launch

X1 EcoChain Partners with Symbiosis to Pioneer Cross-Chain Interoperability Ahead of Mainnet Launch

X1 EcoChain and Symbiosis are joining forces, making it possible to move assets seamlessly across 45-plus chains with mainnet launch right around the corner.
Share
Blockchainreporter2026/03/12 16:00